aragen.com valid
Automatically discovered from public files. Ownership management is optional. Inclusion does not imply endorsement or publisher participation.
Manage this listing — optional · Visit publisher ↗
Verify with your agent
Paste this into your coding agent and it claims the listing for you. Verified sites are listed by name in our llms-full.txt, the file agents read, and get a private dashboard for listing controls, file health, measured activity and score history.
Claim my listing on Agent Web Map for aragen.com:
1. POST https://agentwebmap.com/v1/sites/aragen.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://aragen.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/aragen.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/aragen.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verifyCorrections or removal requests: contact the directory. Ownership management is optional.
Aragen Life Sciences
Aragen is a fully integrated, technology\-led CRDMO supporting discovery, development and manufacturing for small molecules and biologics\.
Their llms.txt
The beginning of the file, from our validated copy saved 2026-10-21T09:13:11.902Z. Cached copy · Source on aragen.com
# Aragen Life Sciences
> Aragen is a fully integrated, technology\-led CRDMO supporting discovery, development and manufacturing for small molecules and biologics\.
Generated by Yoast SEO v28.6, this is an llms.txt file, meant for consumption by LLMs.
## Pages
- [Biomedical Waste Returns](https://www.aragen.com/ehs/)
- [CPHI Frankfurt 2025](https://www.aragen.com/cphi-frankfurt-2025/)
- [Thank You \- Protein Degraders](https://www.aragen.com/thank-you-protein-degraders/)
- [Corporate Governance](https://www.aragen.com/corporate-governance/)
- [CPHI Japan 2026](https://www.aragen.com/cphi-japan-2026/)
## Posts
- [Enabling Faster Decisions: The Role of Predictable Turnaround Times in DMPK Programs](https://www.aragen.com/enabling-faster-decisions-the-role-of-guaranteed-tat-in-dmpk-programs/)
- [Bridging Material Science and Particle Science: A Roadmap from Molecular Pharmaceutics to Manufacturing Scale](https://www.aragen.com/bridging-material-science-and-particle-science-a-roadmap-from-molecular-pharmaceutics-to-manufacturing-scale/)
- [Faster from Gene to Protein: Building Confidence into Every Development Decision](https://www.aragen.com/faster-from-gene-to-protein-building-confidence-into-every-development-decision/)
- [Choosing the Right CRO for \<i\>In Vivo\</i\> Research](https://www.aragen.com/choosing-the-right-cro-for-in-vivo-research/)
- [Allometric Scaling for Peptides: Myths, Pitfalls, and Predictive Strategies](https://www.aragen.com/allometric-scaling-for-peptides-myths-pitfalls-and-predictive-strategies/)
## Solutions
- [OneHP Platform](https://www.aragen.com/solutions/small-molecules/development/onehp-platform/)
- [Recombinant Protein Production](https://www.aragen.com/solutions/small-molecules/discovery/biology/cell-and-protein-sciences/recombinant-protein-production/): Recombinant protein production using multiple expression platforms to deliver high\-quality, proteins for your research needs\.
- [Protein Characterization](https://www.aragen.com/solutions/small-molecules/discovery/biology/cell-and-protein-sciences/protein-characterization/): Extensive characterization of the purified proteins to deliver high\-quality proteins\.
- [Technology Transfer](https://www.aragen.com/solutions/small-molecules/development/drug-substance/technology-transfer/): Ensures seamless drug substance technology transfer across all phases, mitigating technical, regulatory, and quality risks for successful commercial\-scale production\.
- [Process Safety and Risk Management](https://www.aragen.com/solutions/small-molecules/development/drug-substance/process-safety-and-risk-management/): Aragen ensures process safety and risk management across all phases, using advanced screening, risk assessments, and regulatory compliance for secure development\.
## News
- [India’s race for the CDMO crown](https://www.aragen.com/news/indias-race-for-the-cdmo-crown/)
- [Aragen Life Sciences to begin Operations at OneHP, an Integrated High\-potency Platform in Hyd
…
Related sites
Other listed sites in Industry and manufacturing. See the whole category →
| Domain | Title | Category | Country | Authority | llms.txt | llms-full.txt |
|---|---|---|---|---|---|---|
| opentext.com | OpenText | documentation Cybersecurity Finance and payments +2 | CA | 70 | ✓ | ✓ |
| intel.com | Intel Corporation | documentation Industry and manufacturing | US | 69 | ✓ | ✓ |
| ghostscript.com | Ghostscript | documentation Industry and manufacturing | US | 67 | ✓ | ✓ |
| clariant.com | Meet Clariant at SEPAWA 2026 | informational Industry and manufacturing | CH | 65 | ✓ | ✓ |
| ni.com | NI (National Instruments) is a product brand of the Emerson Test & Measurement business group. | documentation Industry and manufacturing | 65 | ✓ | ||
| api.org | American Petroleum Institute (API) | informational Industry and manufacturing | US | 64 | ✓ | |
| datacolor.com | Datacolor | documentation Industry and manufacturing | DE | 64 | ✓ | ✓ |
| packagingeurope.com | Packaging Europe | documentation Industry and manufacturing | NL | 64 | ✓ | ✓ |
Help agents understand your site
Optionally manage your description, publish terms for agents, review file health, measured discovery requests, publisher clicks and score history. Confirm domain control in your browser using a fresh token in your llms.txt, DNS, meta tag or well-known file. No backlink is required.
Manage this listing → · Agent and API instructions
Machine-readable: GET /v1/resolve?q=aragen.com · GET /v1/domain/aragen.com · this page as Accept: application/json or text/markdown · MCP lookup_domain